Lineage Cell Therapeutics
LCTX
#8221
Rank
C$0.22 B
Marketcap
$1.18
Share price
1.22%
Change (1 day)
-32.35%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$49.44 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are C$49.44 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$51.72 M-26.31%
2022-12-31C$70.19 M-34.16%
2021-12-31C$0.10 B552.05%
2020-12-31C$16.34 M-12.04%
2019-12-31C$18.58 M44.94%
2018-12-31C$12.82 M13.61%
2017-12-31C$11.28 M-30.38%
2016-12-31C$16.21 M-35.83%
2015-12-31C$25.26 M78.78%
2014-12-31C$14.13 M-14.17%
2013-12-31C$16.46 M203.58%
2012-12-31C$5.42 M21.97%
2011-12-31C$4.44 M15.64%
2010-12-31C$3.84 M53.17%
2009-12-31C$2.51 M-61.64%
2008-12-31C$6.54 M103.63%
2007-12-31C$3.21 M9.72%
2006-12-31C$2.92 M16.72%
2005-12-31C$2.5 M77.53%
2004-12-31C$1.41 M-68.89%
2003-12-31C$4.54 M7.84%
2002-12-31C$4.21 M29.6%
2001-12-31C$3.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$36.47 M-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA